These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24120758)

  • 21. Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells.
    Zaman S; Wang R; Gandhi V
    Exp Hematol; 2015 Nov; 43(11):951-962.e3. PubMed ID: 26257207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis.
    Le Gouill S; Podar K; Amiot M; Hideshima T; Chauhan D; Ishitsuka K; Kumar S; Raje N; Richardson PG; Harousseau JL; Anderson KC
    Blood; 2004 Nov; 104(9):2886-92. PubMed ID: 15217829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
    Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
    Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1.
    Schache P; Gürlevik E; Strüver N; Woller N; Malek N; Zender L; Manns M; Wirth T; Kühnel F; Kubicka S
    Gene Ther; 2009 Jul; 16(7):849-61. PubMed ID: 19369968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
    Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
    Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y
    Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun.
    Keim A; Rössler OG; Rothhaar TL; Thiel G
    Neuroscience; 2012 Mar; 206():25-38. PubMed ID: 22260869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition.
    Hu J; Dang N; Menu E; De Bruyne E; Xu D; Van Camp B; Van Valckenborgh E; Vanderkerken K
    Blood; 2012 Jan; 119(3):826-37. PubMed ID: 22128141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis.
    Balsas P; López-Royuela N; Galán-Malo P; Anel A; Marzo I; Naval J
    Biochem Pharmacol; 2009 Mar; 77(5):804-12. PubMed ID: 19100720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.
    Bruncko M; Wang L; Sheppard GS; Phillips DC; Tahir SK; Xue J; Erickson S; Fidanze S; Fry E; Hasvold L; Jenkins GJ; Jin S; Judge RA; Kovar PJ; Madar D; Nimmer P; Park C; Petros AM; Rosenberg SH; Smith ML; Song X; Sun C; Tao ZF; Wang X; Xiao Y; Zhang H; Tse C; Leverson JD; Elmore SW; Souers AJ
    J Med Chem; 2015 Mar; 58(5):2180-94. PubMed ID: 25679114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model.
    Choi ES; Jung JY; Lee JS; Park JH; Cho NP; Cho SD
    Cancer Lett; 2013 Jan; 328(1):65-72. PubMed ID: 23000424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.
    Ponder KG; Matulis SM; Hitosugi S; Gupta VA; Sharp C; Burrows F; Nooka AK; Kaufman JL; Lonial S; Boise LH
    Cancer Biol Ther; 2016 Jul; 17(7):769-77. PubMed ID: 27246906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
    Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ
    Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.
    Zhou W; Hu J; Tang H; Wang D; Huang X; He C; Zhu H
    BMC Cancer; 2011 Nov; 11():485. PubMed ID: 22078414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.
    Tron AE; Belmonte MA; Adam A; Aquila BM; Boise LH; Chiarparin E; Cidado J; Embrey KJ; Gangl E; Gibbons FD; Gregory GP; Hargreaves D; Hendricks JA; Johannes JW; Johnstone RW; Kazmirski SL; Kettle JG; Lamb ML; Matulis SM; Nooka AK; Packer MJ; Peng B; Rawlins PB; Robbins DW; Schuller AG; Su N; Yang W; Ye Q; Zheng X; Secrist JP; Clark EA; Wilson DM; Fawell SE; Hird AW
    Nat Commun; 2018 Dec; 9(1):5341. PubMed ID: 30559424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells.
    Pei XY; Dai Y; Grant S
    Leukemia; 2003 Oct; 17(10):2036-45. PubMed ID: 14513055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
    Gauduchon J; Gouilleux F; Maillard S; Marsaud V; Renoir JM; Sola B
    Clin Cancer Res; 2005 Mar; 11(6):2345-54. PubMed ID: 15788686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.
    Baumann P; Müller K; Mandl-Weber S; Leban J; Doblhofer R; Ammendola A; Baumgartner R; Oduncu F; Schmidmaier R
    Br J Haematol; 2009 Mar; 144(6):875-86. PubMed ID: 19170678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bortezomib sensitizes human glioblastoma cells to induction of apoptosis by type I interferons through NOXA expression and Mcl-1 cleavage.
    Wang R; Davidoff AM; Pfeffer LM
    Biochem Biophys Res Commun; 2016 Sep; 478(1):128-134. PubMed ID: 27450810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.